Retraction Note: Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injury

Ítems similars

• Retraction Note: Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injury
  per: Nimesh S. A Patel, et al.
  Publicat: (2026-02-01)
• Correction of renal ischemia/reperfusion injury with the combination of Infliximab and the erythropoietin-derived peptide mimetic pHBSP
  per: Aleksandr S. Netrebenko
  Publicat: (2023-06-01)
• Suppression of Coronary Atherosclerosis by Helix B Surface Peptide, a Nonerythropoietic, Tissue-Protective Compound Derived from Erythropoietin
  per: Hiroto Ueba, et al.
  Publicat: (2013-05-01)
• Pharmacological preconditioning with erythropoietin attenuates the organ injury and dysfunction induced in a rat model of hemorrhagic shock
  per: Kiran K. Nandra, et al.
  Publicat: (2013-05-01)
• Erythropoietin attenuates cardiac dysfunction in experimental sepsis in mice via activation of the β-common receptor
  per: Areeg I. Khan, et al.
  Publicat: (2013-07-01)